BOCK MARK,HAO MING HONG,KORPAL MANAV,NYAVANANDI VIJAY KUMAR,PUYANG XIAOLING,SAMAJDAR SUSANTA,SMITH PETER GERARD,WANG JOHN,ZHENG GUO ZHU,ZHU PING
申请号：
IN201747046812
公开号：
IN201747046812A
申请日:
2017.12.27
申请国别(地区):
IN
年份:
2018
代理人:
摘要：
Disclosed herein are compounds or pharmaceutically acceptable salts thereof and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER positive breast cancer and/or the subject in need of treatment may express a mutant ER protein.
